Menu
Recruiting NCT06802419

Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries

No phase Interventional Continuous Adductor Canal Block Infiltration Between The Popliteal Artery and Capsule of The Knee Arthroscopic Knee Surgeries

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Continuous adductor canal block, Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule.
Who it may be relevant to
Registry conditions: Continuous Adductor Canal Block, Infiltration Between The Popliteal Artery and Capsule of The Knee, Arthroscopic Knee Surgeries. Basic parameters: 21 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Comparative Study Between the Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries

Overview

This study aims to evaluate the effect of Continuous Adductor Canal Block only versus adding posterior knee block, known as the Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block with Continuous Adductor Canal Block (CACB) after arthroscopic knee surgeries.

Detailed description

Enhanced recovery after arthroscopic knee surgery is gaining popularity in orthopedic surgeries. Motor preservation with adequate analgesia has become the optimal postoperative goal, enabling earlier physical therapy, faster recovery, and early hospital discharge. Spinal anesthesia for knee arthroscopy has favorable outcome effects compared with general anesthesia. The positive physiological effects of the provided sympathetic blockade with less blood loss, increased leg blood flow, and better initial pain relief explain this.

An ideal nerve block that targets the sensory nerves and spares the motor function can facilitate early ambulation and rehabilitation, a major goal for patients undergoing arthroscopic knee surgery.

A novel technique for posterior knee block, known as the infiltration between the popliteal artery and capsule of the knee (IPACK) block combined with continuous adductor canal block (CACB) would reduce opioid requirements.

Interventions

  • Other Continuous adductor canal block
    Patients will receive continuous adductor canal block.
  • Other Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule
    Patients will receive Continuous Adductor Canal Block with additional Infiltration between The Popliteal Artery and Capsule of The Knee

Primary outcome measures

  • Degree of pain [Time frame: 24 hours postoperatively]
Secondary outcome measures (4)
  • Total Nalbuphine consumption [Time frame: 24 hours postoperatively]
  • Straight leg rise [Time frame: 24 hours postoperatively]
  • Range of motion [Time frame: 24 hours postoperatively]
  • Rate of complications [Time frame: 24 hours postoperatively]

Eligibility criteria

Inclusion criteria

  • Age from 21 to 65 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) Physical Status Class I to II.
  • Patients with successful spinal anesthesia.
  • Patients scheduled for elective arthroscopic knee surgery for anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) repair.

Exclusion criteria

  • Declining to give written informed consent.
  • History of allergy to the medications used in the study.
  • Contraindications to regional anesthesia (including coagulopathy and local infection).
  • Polytrauma patients having lower limb fractures.
  • Patients with pre-existing myopathy or neuropathy on the operating limb.
  • Patients with diabetes mellitus.
  • Psychiatric disorder.
  • Morbid obesity \[body mass index (BMI) > 45kg/m2\].
  • Complicated Surgery.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Ain Shams University — Cairo

Identifiers

NCT: NCT06802419 · FMASU MD134/2024

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗